Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB-747651A dihydrochloride是一种与ATP竞争性相互作用的抑制剂,特别针对丝裂原和应激激活激酶1 (MSK1),IC50值为11 nM。此化合物还能抑制PRK2、RSK1、p70S6K和ROCK-II等酶的活性。因其对上述激酶的抑制作用,SB-747651A dihydrochloride在炎症研究中显示出潜力。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 738 | 现货 | ||
5 mg | ¥ 1,830 | 现货 | ||
10 mg | ¥ 2,680 | 现货 | ||
25 mg | ¥ 4,480 | 现货 | ||
50 mg | ¥ 6,390 | 现货 | ||
100 mg | ¥ 8,730 | 现货 | ||
500 mg | ¥ 17,500 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,870 | 现货 |
产品描述 | SB-747651A dihydrochloride is a chemical compound that serves as an ATP-competitive inhibitor for mitogen- and stress-activated kinase 1 (MSK1), featuring an IC50 of 11 nM. Additionally, this compound effectively inhibits PRK2, RSK1, p70S6K, and ROCK-II, showcasing its potential in inflammation research [1]. |
体外活性 | SB-747651A dihydrochloride (5 μM; neutrophils) affects CXCL2-induced intraluminal crawling of neutrophils in a Mac-1-dependent manner. SB-747651A dihydrochloride prevents the intraluminal crawling of adherent neutrophils to optimal sites of emigration. SB-747651A dihydrochloride (5 μM; neutrophils) significantly increases transmigration time and detachment time. SB-747651A dihydrochloride affects mechanisms that regulate transendothelial migration of neutrophils in response to CXCL2 chemotactic gradient. SB-747651A dihydrochloride inhibits the migration speed of extravascular chemotaxing neutrophils but does not affect their directionality in response to CXCL2 chemotactic gradient [2]. |
体内活性 | SB747651A (3 mg/kg; intrascrotal injection) dihydrochloride causes increased neutrophil adhesion 3.5~4.5 hours following stimulation with CXCL2 as compared to the effect of CXCL2 [3]. SB-747651A (3 mg/kg; i.p.) dihydrochloride affects neutrophil extravasation by increasing neutrophil emigration only at 3 and 4 hours in mouse peritonitis model of acute inflammation [3]. Animal Model: Male C57BL/6N mice (8~16 weeks) [3] Dosage: 3 mg/kg Administration: Intrascrotal injection Result: Resulted in increased neutrophil adhesion 3.5~4.5 hours following stimulation with CXCL2 as compared to the effect of CXCL2. |
分子量 | 415.32 |
分子式 | C16H24Cl2N8O |
CAS No. | 1781882-72-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (120.39 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4078 mL | 12.0389 mL | 24.0778 mL | 60.1945 mL |
5 mM | 0.4816 mL | 2.4078 mL | 4.8156 mL | 12.0389 mL | |
10 mM | 0.2408 mL | 1.2039 mL | 2.4078 mL | 6.0195 mL | |
20 mM | 0.1204 mL | 0.6019 mL | 1.2039 mL | 3.0097 mL | |
50 mM | 0.0482 mL | 0.2408 mL | 0.4816 mL | 1.2039 mL | |
100 mM | 0.0241 mL | 0.1204 mL | 0.2408 mL | 0.6019 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SB-747651A Dihydrochloride 1781882-72-1 Cell Cycle/Checkpoint Cytoskeletal Signaling Stem Cells ROCK SB747651A Dihydrochloride SB 747651A Dihydrochloride SB-747651A Inhibitor inhibitor inhibit